Beijing Richen-Force Science & Technology

About Beijing Richen-Force Science & Technology

Founded in July 2002, Beijing Richen-Force Science & Technology Co., Ltd. operates from its headquarters in Beijing's Zhongguancun Science and Technology Park. The company has established itself as a specialized manufacturer and marketer of high-tech medical devices for the gastroenterology sector. Its business model revolves around the in-house research, development, production, and sale of these devices, serving a global client base across more than 60 countries. The company generates revenue by selling its diagnostic products directly to over 6,000 customers, which primarily include hospitals and medical institutions.

The company's core offering is its 13C-Urea Breath Test (UBT) system, designed for the non-invasive diagnosis of Helicobacter pylori (H. pylori) infection, a key factor in various gastric diseases. This system includes 13C Infrared Spectrometers and the accompanying 13C Urea Breath Test Kits, which are marketed under the "Heliforce" brand. The procedure is promoted as being non-invasive, painless, safe, and simple to use. Development of these diagnostic products began in 2004, and they have since become a widely accepted standard for H. pylori diagnosis due to their high sensitivity and specificity. Beyond the UBT system, the company's product portfolio includes capsule endoscopies, endoscopy heat probe treatment systems, and H2 breath tests. The company holds independent intellectual property patents for its technology and has secured certifications such as CE, ISO, and GMP.

Starting in the 1990s, before the company's formal establishment, the founders began developing the carbon 13 urea breath detection system. This early focus on H. pylori and gastric cancer prevention laid the groundwork for the company's future. A significant milestone was achieved in 2015 when the European Helicobacter and Microbiota Study Group appointed Richen as a Certified Partner for its 13C Urea Breath Test products, recognizing its contributions to the field. The company has expanded its global footprint by establishing R&D centers and production bases in Beijing, Guangzhou, and Taizhou, along with subsidiary companies in Italy, Brazil, and a research center in the USA.